Clinical Trial: Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07532148) titled 'Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer' on April 09.

Brief Summary: Clinical Trial to evaluate the pharmacokinetic Characteristics, safety and Tolerability among CKD-215 and D215

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Ovarian Cancer

Intervention: DRUG: CKD-215

2 tablets BID at 12-hour intervals for 7 days

DRUG: D215

2 tablets BID at 12-hour intervals for 7 days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chong Kun Dang Pharmaceutical

Published by HT Digital Content Services with permission from Health Daily Dige...